WITHDRAWN: Appraisal of Bone Targeting Potential of Nanohydroxyapatite Based Drug Carriers Conjugated with Pamidronate in Osteoporosis Treatment

(E-pub Ahead of Print)

Author(s): Purnima Rawat, Shindu C Thomas, Farhan Jalees Ahmad, Sushama Talegaonkar*

Journal Name: Pharmaceutical Nanotechnology

Become EABM
Become Reviewer
Call for Editor


Bentham Science has decided to withdraw this article from the journal in accordance with BSP Editorial Policies and apologizes to its readers for any inconvenience this may cause.

Bentham Science Disclaimer:

It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously submitted or published elsewhere. Furthermore, any data, illustration, structure or table that has been published elsewhere must be reported, and copyright permission for reproduction must be obtained. Plagiarism is strictly forbidden, and by submitting the article for publication the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism or fabricated information is discovered. By submitting a manuscript the authors agree that the copyright of their article is transferred to the publishers if and when the article is accepted for publication.

Rights & PermissionsPrintExport Cite as

Article Details

Published on: 05 December, 2019
(E-pub Ahead of Print)
DOI: 10.2174/2211738507666191205141718

Article Metrics

PDF: 205